Trump threatens 100% tariff on US drug makers that don’t strike deals to lower prices
#Trump #tariffs #drug prices #pharmaceutical #healthcare #trade policy #prescription drugs
📌 Key Takeaways
- Trump proposes 100% tariffs on US drug makers failing to negotiate lower drug prices.
- The policy aims to pressure pharmaceutical companies to reduce prescription drug costs.
- It represents a significant shift in trade policy targeting domestic manufacturers.
- The threat could impact drug pricing strategies and industry negotiations.
📖 Full Retelling
<p>New tax will hit branded drugs and active ingredients while exempting generics for at least one year</p><ul><li><p><a href="https://www.theguardian.com/news/2026/feb/17/sign-up-for-the-breaking-news-us-email-to-get-newsletter-alerts-direct-to-your-inbox?utm_medium=ACQUISITIONS_STANDFIRST&utm_campaign=BN22326&utm_content=signup&utm_term=standfirst&utm_source=GUARDIAN_WEB">Sign up for the Breaking News US email to get newslette
🏷️ Themes
Healthcare Policy, Trade Tariffs
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
<p>New tax will hit branded drugs and active ingredients while exempting generics for at least one year</p><ul><li><p><a href="https://www.theguardian.com/news/2026/feb/17/sign-up-for-the-breaking-news-us-email-to-get-newsletter-alerts-direct-to-your-inbox?utm_medium=ACQUISITIONS_STANDFIRST&utm_campaign=BN22326&utm_content=signup&utm_term=standfirst&utm_source=GUARDIAN_WEB">Sign up for the Breaking News US email to get newslette
Read full article at source